843
Views
18
CrossRef citations to date
0
Altmetric
Original Research

Urbanization and Daily Exposure to Biomass Fuel Smoke Both Contribute to Chronic Bronchitis Risk in a Population with Low Prevalence of Daily Tobacco Smoking

, , , , , , , , & show all

References

  • Lozano R, Naghavi M, Foreman K, et al.Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2095–128.
  • Burgel PR. Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD Subjects. Chest 2009; 135:975.
  • Medical Research Council. Definition and classification of chronic bronchitis for clinical and epidemiological purposes. A report to the Medical Research Council by their Committee on the Aetiology of Chronic Bronchitis. Lancet 1965; 1:775–779.
  • Guerra S, Sherrill DL, Venker C, et al.Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk. Thorax 2009; 64:894–900.
  • Kim V, Criner GJ. Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187:228–237.
  • American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 152:77–121.
  • Lee J, Cho MH, Hersh CP, et al.Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease. Respir Res 2014; 15:113.
  • Kim V, Davey A, Comellas AP, et al.Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study. Respir Res 2014; 15:52.
  • de Oca MM, Halbert RJ, Lopez MV, et al.The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study. Eur Respir J 2012; 40:28–36.
  • Pelkonen M, Notkola IL, Nissinen A, et al.Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men. Chest 2006; 130:1129–1137.
  • Pelkonen MK, Notkola IL, Laatikainen TK, et al.Twenty-five year trends in prevalence of chronic bronchitis and the trends in relation to smoking. Respir Med 2014; 108:1633–1640.
  • Accordini S, Corsico AG, Cerveri I, et al.Diverging trends of chronic bronchitis and smoking habits between 1998 and 2010. Respir Res 2013; 14:16.
  • Vestbo J, Hurd SS, Agusti AG, et al.Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187:347–365.
  • World Health Organization. WHO STEPwise Approach to Survalance (STEPS). Available from: http://www.who.int/chp/steps/manual/en/index.html. http://www.who.int/chp/steps/manual/en/index.html ( accessed 31 May 2014).
  • Lu M, Yao W, Zhong N, et al.Chronic obstructive pulmonary disease in the absence of chronic bronchitis in China. Respirology 2010; 15:1072–1078.
  • World Health Organization. Prioritized Research Agenda for Prevention and Control of Noncommunicable Diseases. World Health Organization, Geneva, 2011.
  • Miranda JJ, Bernabe-Ortiz A, Smeeth L, et al.Addressing geographical variation in the progression of non-communicable diseases in Peru: the CRONICAS cohort study protocol. BMJ Open 2012; 2:e000610–0.
  • Miller MR, Hankinson J, Brusasco V, et al.Standardisation of spirometry. Eur Respir J 2005; 26:319–338.
  • Menezes AM, Perez-Padilla R, Jardim JB, et al.Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366:1875–1881.
  • Howe LD, Galobardes B, Matijasevich A, et al.Measuring socio-economic position for epidemiological studies in low- and middle-income countries: a methods of measurement in epidemiology paper. Int J Epidemiol 2012; 41:871–886.
  • Jaganath D, Miranda JJ, Gilman RH, et al.Prevalence of chronic obstructive pulmonary disease and variation in risk factors across four geographically diverse resource-limited settings in Peru. Respir Res 2015; 16:40.
  • Miller MR. Standardisation of spirometry. Eur Respir J 2005; 26:319–338.
  • Ferguson GT, Enright PL, Buist AS et al. Office spirometry for lung health assessment in adults: A consensus statement from the National Lung Health Education Program. Chest 2000; 117:1146–1161.
  • Pollard SL, Williams DAL, Breysse PN, et al.A cross-sectional study of determinants of indoorenvironmental exposures in households with and without chronic exposure to biomass fuel smoke. Environ Health 2014; 13:1–12.
  • Quintana PJ, Samimi BS, Kleinman MT, et al.Evaluation of a real-time passive personal particle monitor in fixed site residential indoor and ambient measurements. J Expo Anal Environ Epidemiol 2000; 10: 437–45.
  • Menezes AM, Victora CG, Rigatto M. Prevalence and risk factors for chronic bronchitis in Pelotas, RS, Brazil: a population-based study. Thorax 1994; 49:1217–1221.
  • Caballero A, Torres-Duque CA, Jaramillo C, et al. Prevalence of COPD in Five Colombian Cities Situated at Low, Medium, and High Altitude (PREPOCOL Study). Chest 2008; 133:343.
  • Quanjer PH, Stanojevic S, Cole TJ, Baur X, Hall GL, Culver BH, et al.Multi–ethnic reference values for spirometry for the 3–95-yr age range: the global lung function 2012 equations. Eur Respir J 2012; 40:1324–1343.
  • Hankinson JL, Odencrantz, KR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159:79–187.
  • Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996; 153:1530–1535.
  • Buist AS, McBurnie MA, Vollmer WM, et al.International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study. Lancet 2007; 370:741–750.
  • Alberti KG, Eckel RH, Grundy SM, et al.Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009; 120:1640–1645.
  • Rivera RM, Cosio MG, Ghezzo H, et al.Comparison of lung morphology in COPD secondary to cigarette and biomass smoke. Int J Tuberc Lung Dis 2008; 12:972–977.
  • Po JY, FitzGerald JM, Carlsten C. Respiratory disease associated with solid biomass fuel exposure in rural women and children: systematic review and meta-analysis. Thorax 2011; 66:232–239.
  • Zhou Y, Zou Y, Li X, et al.Lung Function and Incidence of Chronic Obstructive Pulmonary Disease after Improved Cooking Fuels and Kitchen Ventilation: A 9-Year Prospective Cohort Study. PLoS Med 2014; 11:e1001621.
  • Baumann LM, Robinson CL, Combe JM, et al.Effects of distance from a heavily transited avenue on asthma and atopy in a periurban shantytown in Lima, Peru. J Allergy Clin Immunol 2011; 127:875–882.
  • Lindgren A, Stroh E, Montnémery P, et al.Traffic-related air pollution associated with prevalence of asthma and COPD/chronic bronchitis. A cross-sectional study in Southern Sweden. Int J Health Geogr 2009; 8:2.
  • Shirtcliffe P, Marsh S, Travers J, et al.Childhood asthma and GOLD-defined chronic obstructive pulmonary disease. Intern Med J 2010; 42:83–88.
  • Allender S, Foster C, Hutchinson L, et al.Quantification of urbanization in relation to chronic diseases in developing countries: A systematic review. J Urban Health 2008; 85:938–951.
  • Izquierdo-Alonso JL, Rodriguez-GonzálezMoro JM, de Lucas-Ramos P, et al.Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD). Respir Med 2013; 107:724–731.
  • Hnizdo E, Singh T, Churchyard G. Chronic pulmonary function impairment caused by initial and recurrent pulmonary tuberculosis following treatment. Thorax 2000; 55:32–38.
  • Brusasco V. Spirometric definition of COPD: exercise in futility or factual debate? Thorax 2012; 67(7):569–570.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.